Similar articles

• Coeliac disease. Pathogenesis and clinical aspects.

  Friis SU. Friis SU. APMIS Suppl. 1996;61:1-48. APMIS Suppl. 1996. PMID: 8765057 No abstract available.
• The evolution in research in prolamin toxicity: from bread to peptide.

  Hekkens WT. Hekkens WT. Bibl Nutr Dieta. 1991;(48):90-104. doi: 10.1159/000420040. Bibl Nutr Dieta. 1991. PMID: 1930127 Review. No abstract available.
• Coeliac disease: characterisation of monoclonal antibodies raised against a synthetic peptide corresponding to amino acid residues 206-217 of A-gliadin.

  Ellis HJ, Doyle AP, Sturgess RP, Ciclitira PJ. Ellis HJ, et al. Gut. 1992 Nov;33(11):1504-7. doi: 10.1136/gut.33.11.1504. Gut. 1992. PMID: 1280610 Free PMC article.
• An analysis of cereals that react with serum antibodies in patients with coeliac disease.

  Troncone R, Auricchio S, De Vincenzi M, Donatiello A, Farris E, Silano V. Troncone R, et al. J Pediatr Gastroenterol Nutr. 1987 May-Jun;6(3):346-50. doi: 10.1097/00005176-198705000-00007. J Pediatr Gastroenterol Nutr. 1987. PMID: 3430243
• Celiac disease: adenovirus and alpha gliadin.

  Kagnoff MF. Kagnoff MF. Curr Top Microbiol Immunol. 1989;145:67-78. doi: 10.1007/978-3-642-74594-2_6. Curr Top Microbiol Immunol. 1989. PMID: 2553337 Review. No abstract available.